|
Prostate cancer is the most common male malignancy in many Western countries, the lower incidence of prostate cancer. But in recent years, with the aging of the population and the improvement of the living conditions, significantly increased morbidity. In order to explore the effective treatment of prostate cancer and efficacy, we analyzed the clinical data of 76 cases of patients with prostate cancer in January 1997 -2002 in December. The patients were 76 cases of the (T1 5 cases, 17 cases of T2 stage, T3 in 40 cases, T4, 14 cases). Digital rectal examination (DRE), prostate hard or induration 71 cases; PSA check the 76 cases, the PSA lt; 4ng/ml in 5 cases, PSA gt; 71 cases of 4ng/ml; uneven 71 cases of prostate echo color Doppler ultrasound examination, extracapsular 54 cases of infiltration; transrectal needle biopsy of 73 cases were confirmed as adenocarcinoma. T1, 5 cases, 3 cases of double orchiectomy plus diethylstilbestrol treatment, watchful waiting, the treatment of patients with flutamide; T2 in 17 cases, 4 cases radical prostatectomy, 7 cases orchiectomy plus diethylstilbestrol treatment, 6 cases of testicular resection plus flutamide treatment; T3 of 40 cases, 24 cases were double orchiectomy plus diethylstilbestrol treatment, 16 patients underwent orchiectomy plus flutamide treatment; T4 period 14 cases, 6 cases of testicular resection and diethylstilbestrol treatment, 5 patients underwent orchiectomy plus flutamide therapy, 3 underwent orchiectomy plus estramustine phosphate. 58 patients were followed up for 1-7 years, including symptoms, digital rectal examination, PSA, transrectal ultrasound, isotope scanning. Rectal attending local lesions was significantly reduced 42 cases, qualitative change in the soft, PSA lt; 4ng/ml 36 cases of bone scan showed two cases of bone metastases was significantly reduced. Survived five cases of T1 and T2, 4 cases radical prostatectomy patients follow-up period, the follow-up period 14 patients died, died of lt; WP = 21 gt; five cases of cardiogenic disease died of tumor metastasis 9 cases. In addition to the patient's life expectancy, physical condition and other factors, the treatment of prostate cancer, mainly based on clinical stage, histological grade. High degree of differentiation in patients with T1, watchful waiting, otherwise viable radical mastectomy T1 of better prognosis; T2 patients with conditions suitable to radical surgery, radical prostatectomy is an effective treatment of early prostate cancer patients, efficacy . T3, T4 of patients take androgen deprivation therapy (including medical castration) combined therapy can alleviate clinical symptoms.
|